RCB 50 Pfizer Pill - blue & yellow capsule/oblong, 16mm
Generic Name: ritlecitinib
Pill with imprint RCB 50 Pfizer is Blue & Yellow, Capsule/Oblong and has been identified as Litfulo 50 mg. It is supplied by Pfizer Inc.
Litfulo is used in the treatment of Alopecia and belongs to the drug class selective immunosuppressants. Litfulo 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RCB 50 Pfizer
Litfulo
- Generic Name
- ritlecitinib
- Imprint
- RCB 50 Pfizer
- Strength
- 50 mg
- Color
- Blue & Yellow
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0334
See also:
Kenalog-40
Kenalog-40 is a long-acting corticosteroid injection for intramuscular (into the muscle) or ...
Olumiant
Olumiant is used to treat rheumatoid arthritis, alopecia areata (hair loss), and COVID-19. Includes ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Zilretta
Zilretta (triamcinolone injection) is used for the management of osteoarthritis pain of the knee ...
Rogaine
Rogaine (minoxidil) is used to help regrow new, thicker hair and prevent future hair loss in men ...
Leqselvi
Leqselvi (deuruxolitinib) is a JAK inhibitor used for the treatment of severe hair loss (alopecia ...
Azmacort
Azmacort (triamcinolone) is used to prevent asthma attacks. Includes Azmacort side effects ...
Baricitinib
Baricitinib (brand name Olumiant) is used to treat rheumatoid arthritis, alopecia areata (hair ...
Minoxidil topical
Minoxidil topical is a hair loss treatment that helps regrow hair and prevent future hair loss in ...
More about Litfulo (ritlecitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.